You may also like
PHVT Disruptive Technology Could Revolutionize Heart Failure Treatment
The early clinical promise of percutaneous heart valve technology-a group of minimally invasive devices designed to treat cardiac valve dysfunction without the need for cardiopulmonary bypass-could one day play a prominent role in curbing the costs associated with treating heart failure, which is the current number-one driver of hospitalization among Medicare patients.
Pre-Operative Serum Albumin Concentration as a Predictor of Mortality and Morbidity Following Cardiac Surgery
Pre-operative hypoalbuminaemia is associated with worse outcomes after non-cardiac surgery,
Deep Hypothermia: Rapid Cooling & Nitroglycerine
Editor’s Note: Deep Hypothermic Circulatory Arrest (DHCA), is a concept discussed here in this forum, as well as a significant perfusion event […]